# Environmental Pollution and Its Impact on Kidney Diseases: A Comprehensive Review of Current Evidence

**Authors:** Seung Eun Lee, Yong Seek Park

PMC · DOI: 10.3390/life16020291 · 2026-02-08

## TL;DR

Environmental pollution contributes to kidney disease by causing damage through various toxic mechanisms, highlighting the need for prevention and policy changes.

## Contribution

This review integrates epidemiological and experimental evidence to reveal how environmental pollutants cause kidney disease through shared molecular pathways.

## Key findings

- Long-term exposure to pollutants like heavy metals and air pollution is linked to kidney injury and disease progression.
- Pollutants impair kidney repair processes and contribute to chronic kidney disease through oxidative stress and inflammation.
- Environmental toxicants affect kidney cells by altering epigenetic and mitochondrial functions.

## Abstract

Kidney disease is a growing global public health challenge that accounts for substantial morbidity, premature mortality, and rising healthcare costs. Although diabetes mellitus and hypertension remain the principal clinical risk factors for renal injury, accumulating evidence indicates that environmental pollution represents an independent and globally pervasive contributor to kidney disease burden. Long-term exposure to environmental toxicants, including heavy metals, ambient air pollutants, persistent organic pollutants, and endocrine-disrupting chemicals, has been consistently associated with acute kidney injury, an accelerated decline in renal function, and progression to end-stage kidney disease. The kidney is characterized by a high perfusion rate, specialized tubular transport systems, and a central role in xenobiotic metabolism and excretion, which confer heightened vulnerability to environmental insults. Experimental and epidemiological studies have demonstrated that pollutant exposure across the life course converges on shared pathogenic mechanisms, including oxidative stress, inflammatory signaling, mitochondrial dysfunction, fibrogenesis, and persistent epigenetic alterations. Importantly, environmental toxicants not only initiate renal injury, but they also impair intrinsic repair processes, exacerbating susceptibility to chronic and progressive kidney disease. This Review integrates population-based epidemiological data with experimental mechanistic evidence to define environmental exposures, renal cellular targets, and convergent molecular pathways underlying pollutant-induced nephrotoxicity, and aims to translate this knowledge into actionable strategies for kidney disease prevention, clinical risk stratification, and evidence-informed environmental policy.

## Linked entities

- **Diseases:** kidney disease (MONDO:0001343), acute kidney injury (MONDO:0002492), end-stage kidney disease (MONDO:0004375), diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, PFAS (phosphoribosylformylglycinamidine synthase) [NCBI Gene 5198] {aka FGAMS, FGAR-AT, FGARAT, GATD8, PURL}, OGA (O-GlcNAcase) [NCBI Gene 10724] {aka MEA5, MGEA5, NCOAT}, HLA-G (major histocompatibility complex, class I, G) [NCBI Gene 3135] {aka MHC-G}, APOL1 (apolipoprotein L1) [NCBI Gene 8542] {aka APO-L, APOL, APOL-I, FSGS4}, HAVCR1 (hepatitis A virus cellular receptor 1) [NCBI Gene 26762] {aka CD365, HAVCR, HAVCR-1, KIM-1, KIM1, TIM}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NAGLU (N-acetyl-alpha-glucosaminidase) [NCBI Gene 4669] {aka CMT2V, MPS-IIIB, MPS3B, NAG, UFHSD}
- **Diseases:** hypertension (MESH:D006973), premature death (MESH:D003643), Microvascular injury (MESH:D017566), tubular and glomerular injury (MESH:D015499), albuminuria (MESH:D000419), glomerulonephritis (MESH:D005921), kidney stone formation (MESH:D007669), dehydration (MESH:D003681), vascular dysfunction (MESH:D002561), vascular homeostasis (MESH:D057772), Toxicity (MESH:D064420), end-stage kidney disease (MESH:D007676), EDCs (MESH:D004700), Organic Pollutants (MESH:D000092124), Kidney Diseases (MESH:D007674), tubular dysfunction (MESH:D005198), Mitochondrial Dysfunction (MESH:D028361), Nephrotoxic Metals (MESH:D013651), Fibrosis (MESH:D005355), vascular toxicity (MESH:D016491), metabolic syndrome (MESH:D024821), disease (MESH:D004194), injury to (MESH:D014947), Inflammation (MESH:D007249), CKD (MESH:D051436), Endothelial Dysfunction (MESH:D014652), diabetes (MESH:D003920), tubular injury (MESH:D000230), kidney failure (MESH:D051437), acute and chronic kidney injury (MESH:D058186), pulmonary inflammation (MESH:D011014), tubular cell injury (MESH:D000236), hypoxic (MESH:D002534), frailty (MESH:D000073496), hypoxia (MESH:D000860), declines in kidney function (MESH:D007680), Metabolic dysregulation (MESH:D021081), renal decline (MESH:D006030), Metabolic (MESH:D008659)
- **Chemicals:** phthalate (MESH:C032279), PCBs (MESH:D011078), Mercury (MESH:D008628), dioxins (MESH:D004147), NO (MESH:D009614), O3 (MESH:D010126), Chemicals (-), hydrocarbons (MESH:D006838), Ochratoxin A (MESH:C025589), carbon nanotubes (MESH:D037742), Uranium (MESH:D014501), lipid (MESH:D008055), ATP (MESH:D000255), ROS (MESH:D017382), Heavy metal (MESH:D019216), organic chemical (MESH:D009930), glucose (MESH:D005947), SO2 (MESH:D013458), arsenic (MESH:D001151), Cadmium (MESH:D002104), Lead (MESH:D007854), Metal (MESH:D008670), CO (MESH:D002248), NO2 (MESH:D009585), Nickel (MESH:D009532), BPA (MESH:C006780), Melamine (MESH:C011907), nitric oxide (MESH:D009569)
- **Species:** Homo sapiens (human, species) [taxon 9606], Aspergillus (genus) [taxon 5052], Penicillium (genus) [taxon 5073], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12941669/full.md

---
Source: https://tomesphere.com/paper/PMC12941669